Skip to main content
Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · IEX Real-Time Price · USD
4.300
+0.110 (2.63%)
At close: Jul 2, 2024, 4:00 PM
4.340
+0.040 (0.93%)
After-hours: Jul 2, 2024, 7:43 PM EDT

Boundless Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20232022
Net Income
-49.43-45.9
Depreciation & Amortization
3.322.55
Share-Based Compensation
3.342.29
Other Operating Activities
-4.071.47
Operating Cash Flow
-46.86-39.6
Capital Expenditures
-0.63-1.07
Change in Investments
-37.6317.2
Investing Cash Flow
-38.2616.13
Share Issuance / Repurchase
0.180.13
Other Financing Activities
97.72-
Financing Cash Flow
97.90.13
Net Cash Flow
12.78-23.34
Free Cash Flow
-47.49-40.66
Free Cash Flow Per Share
-39.05-37.03
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).